BlackRock Global Funds - Global Equity Income Fund A2 (EUR)Register to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 1.9 | 18.5 | -4.5 | 8.8 | 3.8 | |
+/-Cat | 0.0 | 0.2 | -3.8 | 1.5 | -0.6 | |
+/-B’mrk | - | -1.9 | -11.3 | 4.0 | -1.7 | |
Category: Global Equity Income | ||||||
Category Benchmark: Morningstar Gbl High Div Yl... |
Key Stats | ||
NAV 15/05/2024 | EUR 21.99 | |
Day Change | 0.37% | |
Morningstar Category™ | Global Equity Income | |
ISIN | LU0880975056 | |
Fund Size (Mil) 30/04/2024 | USD 905.80 | |
Share Class Size (Mil) 15/05/2024 | USD 218.60 | |
Max Initial Charge | 5.26% | |
Ongoing Charge 15/12/2022 | 1.82% |
Investment Objective: BlackRock Global Funds - Global Equity Income Fund A2 (EUR) |
The Fund seeks an above average income from its equity investments without sacrificing long term capital growth. The Fund invests globally at least 70% of its total assets in the equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, developed markets. Currency exposure is flexibly managed. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Olivia Treharne 01/02/2020 | ||
Molly Greenen 12/01/2022 | ||
Inception Date 12/11/2010 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR USD | Morningstar Gbl High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock Global Funds - Global Equity Income Fund A2 (EUR) | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 4.70 |
AstraZeneca PLC | Healthcare | 3.39 |
Novo Nordisk A/S Class B | Healthcare | 3.27 |
Taiwan Semiconductor Manufacturi... | Technology | 3.14 |
Texas Instruments Inc | Technology | 3.06 |
Increase Decrease New since last portfolio | ||
BlackRock Global Funds - Global Equity Income Fund A2 (EUR) |